Tatva Chintan Pharma Chem Share Price

Tatva Chintan Pharma Chem Share Price

NSE: TATVA
|
Chemicals
|
S Cap
₹ 1,596.20
-₹20.70 (-1.28%)
1D
Last updated 03 Sep, 2026, 15:29 IST

Tatva Chintan Pharma Chem Share Price Today

As of 3 Sep 2026, Tatva Chintan Pharma Chem share price is ₹1,596.20. The stock opened at ₹1,611.00, compared to its previous close of ₹1,616.90. During today's trading session, Tatva Chintan Pharma Chem share price moved in the range of ₹1,590.00 to ₹1,639.50, with an average price of ₹1,614.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹976.40 and a high of ₹1,838.10. On the performance front, Tatva Chintan Pharma Chem share price has increased by 38.15% over the last six months and is up 53.83% on a year-on-year basis.

₹1,590.00
1.28% down today
₹1,639.50
1D LOW
1D HIGH

Tatva Chintan Pharma Chem Returns Calculator

Circuit
L
H
₹1,293.60
₹1,940.20
52-week
L
H
₹976.40
₹1,838.10

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Share Price
ISIN
INE0GK401011
Sector Market Cap
₹ 3,785.77 Cr

Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are used for forming channels in zeolites. Its PTCs are used in heterogeneous multiphase systems, facilitating reactant migration. It operates through the Specialty chemical segment. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. It caters to various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.

Tatva Chintan Pharma Chem Financial Highlights

  • Revenue: Tatva Chintan Pharma Chem reported revenue of ₹509.41 crore in FY26 vs ₹385.03 crore in FY25. It showed an increase of 32.30% on a yearly basis.
  • Operating Profit: Tatva Chintan Pharma Chem reported an operating profit of ₹57.01 crore in FY26 vs ₹7.58 crore in FY25. It showed an increase of 652.11% on a year-on-year basis.
  • Net Profit: Tatva Chintan Pharma Chem reported a net profit of ₹42.05 crore in FY26 vs ₹5.71 crore in FY25. It showed an increase of 636.43% on a yearly basis.

Tatva Chintan Pharma Chem Quarterly Result Highlights

  • Tatva Chintan Pharma Chem reported revenue of ₹169.84 crore in Jun 2026, compared with ₹133.79 crore in Mar 2026, representing an increase of 26.95% on a quarter-on-quarter (QoQ) basis.
  • Tatva Chintan Pharma Chem reported an operating profit of ₹21.11 crore in Jun 2026, compared with ₹16.59 crore in Mar 2026, representing an increase of 27.25% on a quarter-on-quarter (QoQ) basis.
  • Tatva Chintan Pharma Chem reported a profit of ₹15.98 crore in Jun 2026, compared with ₹10.32 crore in Mar 2026, reflecting an increase of 54.84% on a QoQ basis.
  • The earnings per share (EPS) of Tatva Chintan Pharma Chem stood at ₹17.98 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.02%
FII
3.93%
Other DII
0.32%
Retail and other
20.94%
Mutual funds
2.79%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20253.39%
Dec 20254.17%
Mar 20263.82%
Jun 20263.93%
Mkt Cap Cr
3,785.77
P/E
73.66
P/B
4.84
ROE
5.38%
D/E
0.16
ROCE
6.63%
Div. Yield
0.12%
EPS(TTM)
16.71
Turnover
0.54
EV/EBITDA
34.52
Net Margin
7.87%
Op. Margin
18.74%
ROA
5.12%
Quick Ratio
0.76
Curr. Ratio
3.03
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Tatva Chintan has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Tatva Chintan appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Tatva Chintan revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Pidilite Industries1,66,566.0062.2415.3822.61%0.0329.97%104.780.70%0.9823.43
SRF76,981.5035.615.4813.07%0.2713.18%426.520.35%0.6558.18
Linde India54,183.5099.1712.7012.87%0.0217.16%495.720.19%0.4664.59
Gujarat Fluorochemicals51,972.8086.626.657.13%0.228.93%647.230.06%0.4761.69
Navin Fluorine43,813.7055.4811.0216.69%0.0318.14%714.370.10%0.5696.03
Godrej Industries38,352.2017.363.4311.10%6.259.34%52.520.00%0.361.81
Himadri Speciality Chemicals33,312.0041.427.0815.96%0.1619.45%91.620.12%0.7515.05
Deepak Nitrite23,645.8030.184.059.43%0.0210.74%235.740.43%0.7413.85
Aether Industries21,847.7092.898.908.94%0.1510.61%1,725.260.00%0.3313.09
Aarti Industries18,334.0034.533.087.04%0.836.41%164.640.20%0.7511.65

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Tatva Chintan Pharma Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹505.86₹382.71₹393.50₹423.61
Other Income₹3.55₹2.32₹7.51₹5.74
Total Revenue₹509.41₹385.03₹401.01₹429.36
Total Expenses₹452.40₹377.45₹357.45₹380.99
Profit Before Tax₹57.01₹7.58₹43.57₹44.78
Tax₹14.96₹1.87₹13.21-₹0.71
Profit After Tax₹42.05₹5.71₹30.35₹45.49
EPS - Basic₹17.98₹2.44₹13.26₹20.52
EPS - Diluted₹17.98₹2.44₹13.26₹20.52

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹57.01₹7.58₹43.57₹44.78
Income before WC changes₹101.09₹36.89₹72.17₹61.47
Change in Assets-₹87.03-₹2.76₹22.02-₹4.31
Change in Liabilities₹25.10-₹4.85₹12.42-₹20.09
Change in WC-₹61.93-₹7.62₹34.44-₹24.40
Cash flow from Operations₹31.49₹24.77₹98.04₹27.78
Cash flow from Investing-₹115.84-₹65.38-₹120.54-₹101.14
Cash flow from Financing₹78.93₹16.59₹30.52₹37.80
Total Cash Flow-₹5.42-₹24.02₹8.02-₹35.57
Cash (Start of the year)₹11.37₹35.30₹27.37₹63.02
Cash (End of the year)₹5.76₹11.37₹35.30₹27.37

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹654.18₹571.00₹520.81₹446.61
Current Assets₹349.51₹265.25₹297.91₹312.25
Total Assets₹1,003.69₹836.25₹818.72₹758.86
Current Liabilities₹213.14₹96.03₹79.66₹238.69
Net Current Asset₹136.38₹169.22₹218.24₹73.56
Non-Current Liabilities₹8.80₹1.40₹1.97₹5.38
Equity Capital₹781.76₹738.82₹737.08₹514.79
Total Equity & Liabilities₹1,003.69₹836.25₹818.72₹758.86

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹496.30₹366.42₹378.68₹403.04
Other Income₹3.53₹3.56₹7.51₹5.68
Total Revenue₹499.82₹369.98₹386.19₹408.72
Total Expenses₹446.66₹369.52₹343.92₹366.30
Profit Before Tax₹53.17₹0.46₹42.27₹38.83
Tax₹14.08₹0.13₹12.92-₹1.63
Profit After Tax₹39.08₹0.33₹29.35₹40.47
EPS - Basic₹16.71₹0.14₹12.82₹18.26
EPS - Diluted₹16.71₹0.14₹12.82₹18.26

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹53.17₹0.46₹42.27₹38.83
Income before WC changes₹94.46₹28.80₹70.44₹54.65
Change in Assets-₹96.15₹6.47₹24.54₹14.02
Change in Liabilities₹35.10-₹6.83₹14.27-₹37.20
Change in WC-₹61.06-₹0.35₹38.81-₹23.18
Cash flow from Operations₹29.17₹24.01₹102.78₹23.73
Cash flow from Investing-₹115.83-₹65.38-₹120.54-₹101.12
Cash flow from Financing₹78.93₹16.59₹30.54₹37.82
Total Cash Flow-₹7.74-₹24.78₹12.78-₹39.58
Cash (Start of the year)₹9.21₹33.99₹21.19₹60.78
Cash (End of the year)₹1.47₹9.21₹33.99₹21.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹653.43₹571.29₹521.46₹447.25
Current Assets₹341.95₹251.52₹293.61₹307.61
Total Assets₹995.38₹822.80₹815.07₹754.86
Current Liabilities₹228.35₹100.09₹87.21₹244.70
Net Current Asset₹113.60₹151.43₹206.39₹62.91
Non-Current Liabilities₹8.80₹1.40₹1.97₹5.38
Equity Capital₹758.23₹721.31₹725.88₹504.78
Total Equity & Liabilities₹995.38₹822.80₹815.07₹754.86
* All values are in INR Crore
Qty
Bid
7
1596.2
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 7
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.74
Neutral
ATR (14)
65.81
Neutral
STOCH(9,6)
40.56
Neutral
STOCH RSI (14)
33.97
Neutral
ADX(9)
17.4
Bullish
UO(9)
36.65
Neutral
ROC(12)
-4.09
Bearish
WillR(14)
-74.11
Neutral
Period
Simple value
Exponential vaue
5D
1615.56
1615.42
10D
1612.55
1624.83
20D
1664.93
1635.29
50D
1550.73
1560.39
100D
1394.98
1456.94
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Tatva Chintan Pharma Chem Share Price
Tatva Chintan Pharma Chem
Chemicals
Add Stock
Add Another

Tatva Chintan Pharma Chem Share Price FAQs

Tatva Chintan Pharma Chem share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837